Viewing Study NCT05678959


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-02-21 @ 9:56 PM
Study NCT ID: NCT05678959
Status: TERMINATED
Last Update Posted: 2025-10-30
First Post: 2023-01-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Extension Study of Ligelizumab in Food Allergy
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Food Allergy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Food allergy View
None Peanut allergy View
None Oral food challenge (OFC) View
None Immunoglobulin E (IgE) View
None ligelizumab View